Work

Prognostic utility of inflammation biomarkers in a PDAC trial involving the human anti-CTGF antibody pamrevlumab.

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.4_suppl.752

Authors: Mark D. Sternlicht, Dongxia Li, Viet-Tam Nguyen, Mairead Carney, Duo Zhou, Kenneth E. Lipson, Elias Kouchakji, Vincent J. Picozzi, Ewa Carrier, Todd W. Seeley

Institutions: FibroGen (United States), Virginia Mason Medical Center

Language: English

Topic: Pancreatic and Hepatic Oncology Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: FibroGen

OpenAlex ID: W3004568592

Cites:

Cited by: 2

Related to: 10